Search

Jing Wu Phones & Addresses

  • San Mateo, CA
  • Daly City, CA
  • Millbrae, CA
  • Newark, CA

Professional Records

Medicine Doctors

Jing Wu Photo 1

Dr. Jing Ying C Wu, Fremont CA - DDS (Doctor of Dental Surgery)

View page
Specialties:
Dentistry
Address:
4988 Paseo Padre Pkwy Suite 204, Fremont, CA 94555
(510) 792-5551 (Phone), (510) 792-5570 (Fax)
Languages:
English
Jing Wu Photo 2

Jing Wu

View page
Specialties:
Pathology
Neurology
Hematology & Oncology
Jing Wu Photo 3

Jing Wu

View page
Specialties:
Anesthesiology
Pain Medicine
Education:
Sun Yat-Sen University (1982)

Lawyers & Attorneys

Jing Wu Photo 4

Jing Wu - Lawyer

View page
Address:
Accenture
(216) 085-6586 (Office)
Licenses:
Hawaii - Active 2007
Education:
University of Hawaii at Manoa - William S. Richardson School of Law

Resumes

Resumes

Jing Wu Photo 5

Jing Wu San Jose, CA

View page
Work:
Western Digital, Inc

2010 to 2000
Senior Principal Engineer in Western Digital Media Operation

Grandis, Inc

2010 to 2010
Senior research scientist in Spin-Transfer Torque MRAM

Applied Materials, Inc
Santa Clara, CA
2007 to 2010
Process Engineer in R&D

University of Minnesota, Dept. of Chemical Engineering

2000 to 2006
Research Assistant

Chinese Academy of Science

1998 to 2000
Education Assistant

Tsinghua University, Dept. of Materials Science and Engineering

1995 to 1998
Research Assistant

Fujian New Century Computer Co. Ltd
Fuzhou, CN
1993 to 1995
Computer Engineer

Xi'an Jiaotong University

1993 to 1993
Research Assistant

Education:
University of Minnesota
2006
PhD in Materials Science

Tsinghua University
1998
Masters of Science in Materials Science

Xi'an Jiaotong University
1993
Bachelors of Engineering in Electrical Engineering

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jing Wu
Owner
China Cafe
Eating Places
8012 Macarthur Blvd, Oakland, CA 94605
Jing Wu
President
Weihong Vanguard Auto, Inc
2878 Prune Ave, Fremont, CA 94539
39812 Msn Blvd, Fremont, CA 94539
Jing Wu
President
Kuang's, Inc
Business Services at Non-Commercial Site · Nonclassifiable Establishments
739 Washington St, San Francisco, CA 94108
200 Ratto Rd, Alameda, CA 94502
Jing Wu
Owner
China Cafe
Restaurants-Food Delivery
8012 Macarthur Blvd, Oakland, CA 94605
(510) 632-1212
Jing Wu
Owner, Principal
Ye Jing Co
Whol General Groceries
1254 Stockton St, San Francisco, CA 94133
Jing Hsiuan Wu
President
JOJO STUDIO, INC
39843 Cedar Blvd 223, Newark, CA 94560
39843 Cedar Blvd, Newark, CA 94560
Jing Ling Wu
President
GOLD FIELD ENTERPRISES INC
411 Allan St, Daly City, CA 94014
Jing Chun Wu
Managing
Wako, LLC
Japanese Food Restaurant
1695 Solano Ave, Berkeley, CA 94707
Jing Wu
Owner
China Cafe
Eating Places
8012 Macarthur Blvd, Oakland, CA 94605

Publications

Wikipedia

Chin Woo Athletic Associati

View page

It can be found spelled in many ways - Jing Mo, Ching Wu, Jing Wo, Jing Wu etc. ... Jingwu Yingxiong Chen Zhen - a sequel to The Legend of Huo Yuanjia, ...

Wu Jing (actor)

View page

Wu Jing (born April 3, 1974 in Beijing, China), sometimes credited as Jason ...

Us Patents

Compounds For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis

View page
US Patent:
6476263, Nov 5, 2002
Filed:
Apr 3, 2001
Appl. No.:
09/826412
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Jon K. Reel - Carmel IN
Warren J. Porter - Indianapolis IN
Jeffrey S. Nissen - Indianapolis IN
Thomas E. Mabry - Indianapolis IN
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Beverly K. Folmer - Newark DE
James J. Droste - Indianapolis IN
Thomas C. Britton - Carmel IN
James E. Audia - Indianapolis IN
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
C07C23300
US Classification:
564152, 564153, 564159, 564160, 564161, 564 41, 560 41, 562450
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis.

N-(Aryl/Heteroaryl) Amino Acid Derivatives, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6495693, Dec 17, 2002
Filed:
Mar 30, 1999
Appl. No.:
09/280966
Inventors:
James E. Audia - Indianpolis IN
Beverly K. Folmer - Newark DE
Varghese John - San Francisco CA
Lee H. Latimer - Oakland CA
Jeffrey S. Nissen - Indianapolis IN
Warren J. Porter - Indianapolis IN
Eugene D. Thorsett - Moss Beach CA
Jing Wu - San Mateo CA
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
C07D27782
US Classification:
546162, 546163, 548161, 548178, 5483381, 548495, 564156, 564157, 564163, 564168, 560 39, 560 43, 560 41, 514313, 514367, 514400, 514419, 514616, 514620, 514506, 514399, 5143355
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6541466, Apr 1, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915362
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6544978, Apr 8, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915480
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6559141, May 6, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915564
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6579867, Jun 17, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915379
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6632811, Oct 14, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915342
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
514220, 514221
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6635632, Oct 21, 2003
Filed:
Dec 22, 1997
Appl. No.:
08/996422
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421203, 51421204, 51421207, 51421208
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
Jing Wu from San Mateo, CA Get Report